Conference Call
Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics
The conference call for investors and analysts took place on Wednesday, 25 January at 1:00 pm CET.
Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics
The conference call for investors and analysts took place on Wednesday, 25 January at 1:00 pm CET.